BNTC · Benitec Biopharma Inc
United States · RS rating 7 · As of 2026-10-14
| Price | 8.29 USD |
|---|---|
| 1-day change | -3.9% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 8 / 9 / 16 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 15 / 5 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -18.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +49.8% |
| Market cap (USD) | $435.0M |